GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PW Medtech Group Ltd (HKSE:01358) » Definitions » Days Sales Outstanding

PW Medtech Group (HKSE:01358) Days Sales Outstanding : 29.26 (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is PW Medtech Group Days Sales Outstanding?

PW Medtech Group's average Accounts Receivable for the six months ended in Dec. 2024 was HK$73.7 Mil. PW Medtech Group's Revenue for the six months ended in Dec. 2024 was HK$459.6 Mil. Hence, PW Medtech Group's Days Sales Outstanding for the six months ended in Dec. 2024 was 29.26.

The historical rank and industry rank for PW Medtech Group's Days Sales Outstanding or its related term are showing as below:

HKSE:01358' s Days Sales Outstanding Range Over the Past 10 Years
Min: 33.79   Med: 183.41   Max: 325.92
Current: 33.79

During the past 13 years, PW Medtech Group's highest Days Sales Outstanding was 325.92. The lowest was 33.79. And the median was 183.41.

HKSE:01358's Days Sales Outstanding is ranked better than
88.42% of 812 companies
in the Medical Devices & Instruments industry
Industry Median: 65.75 vs HKSE:01358: 33.79

PW Medtech Group's Days Sales Outstanding declined from Dec. 2023 (39.65) to Dec. 2024 (29.26).


PW Medtech Group Days Sales Outstanding Historical Data

The historical data trend for PW Medtech Group's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PW Medtech Group Days Sales Outstanding Chart

PW Medtech Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 185.17 169.97 79.81 40.03 35.43

PW Medtech Group Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.87 44.01 39.65 37.79 29.26

Competitive Comparison of PW Medtech Group's Days Sales Outstanding

For the Medical Instruments & Supplies subindustry, PW Medtech Group's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PW Medtech Group's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PW Medtech Group's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where PW Medtech Group's Days Sales Outstanding falls into.


;
;

PW Medtech Group Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

PW Medtech Group's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

Days Sales Outstanding (A: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (81.438 + 77.927) / 2 ) / 820.936*365
=79.6825 / 820.936*365
=35.43

PW Medtech Group's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding (Q: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2024 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (69.445 + 77.927) / 2 ) / 459.618*365 / 2
=73.686 / 459.618*365 / 2
=29.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PW Medtech Group  (HKSE:01358) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


PW Medtech Group Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of PW Medtech Group's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


PW Medtech Group Business Description

Traded in Other Exchanges
Address
No. 23 Panlong West Road, Building 1, Pinggu District, Beijing, CHN, 101204
PW Medtech Group Ltd is a medical device company with a focus on fast-growing and high-margin segments of China's medical device industry. The company is engaged in the research and development, manufacturing, and sale of the infusion set, intravenous cannula products, and insulin needles. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens. The company operates through three business segments namely Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. It generates maximum revenue from Blood Purification Business. Geographically, it operates in China, North America, India and Others.
Executives
Right Faith Holdings Limited 2101 Beneficial owner
Chan Marc 2201 Interest of corporation controlled by you
Cross Mark Limited 2101 Beneficial owner
Liu Yufeng 2201 Interest of corporation controlled by you
Zhang Zaixian 2202 Interest of your spouse
Fil Limited 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Fidelity China Special Situations Plc 2101 Beneficial owner

PW Medtech Group Headlines

No Headlines